Jpmorgan Chase & Co »

Amicus Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Amicus Therapeutics shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $399k 34k 11.78
2020-12-31 $5.9M 258k 23.09
2020-09-30 $3.2M 230k 14.08
2020-06-30 $2.4M 161k 15.08
2020-03-31 $195k 21k 9.24
2019-12-31 $390k 40k 9.75
2019-06-30 $480k 40k 12.00
2019-03-31 $3.9M 290k 13.60
2018-09-30 $6.6M 550k 12.09
2018-06-30 $3.7M 240k 15.62
2018-03-31 $1.4M 90k 15.04
2017-12-31 $1.4M 100k 14.39
2017-06-30 $403k 40k 10.08
2016-06-30 $382k 70k 5.46

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
SPDR S&P 500 ETF Ser 1 S&P Common (SPY)
Amazon Common (AMZN)
Apple Common (AAPL)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Mastercard Incorporated Common (MA)
Unitedhealth Group Common (UNH)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard index Fds S&P 500 ETF Common (VOO)
Abbvie Common (ABBV)
Exxon Mobil Corp Common (XOM)
Alphabet Common (GOOGL)

View all positions for Jpmorgan Chase & Co

Top funds holding Amicus Therapeutics

Simplex Trading
Jpmorgan Chase & Co
Group One Trading

View all funds holding Amicus Therapeutics